K M C Speciality Hospitals (India) Limited
KMCSHIL · 524520 · Healthcare · Hospital
- Market cap
- Rs 2,436 Cr
- P/E
- 43.67x
- P/B
- 11.58x
- 52W high / low
- No data: the source has not published this figure.
About K M C Speciality Hospitals (India)
K M C Speciality Hospitals (India) Limited is listed on the NSE under the symbol KMCSHIL and on the BSE under scrip code 524520. It is classified in the Healthcare sector, industry: Hospital. It is a constituent of BSE Healthcare. The company listed on 17 Aug 2026 and has a face value of Rs 1.
The latest available end-of-day price is Rs 149.36 (−0.67% on the day), for a market capitalisation of Rs 2,436 Cr. Trailing P/E is 43.67x and price-to-book is 11.58x.
Against the 15-company comparison set from the official BSE basic industry Hospital, its market capitalisation is 0.6 times the peer median of Rs 3,817 Cr, and its P/E of 43.67x compares with a peer median of 38.14x. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For FY26 (year ended 31 Mar 2026), K M C Speciality Hospitals (India) Limited reported revenue of Rs 306 Cr and net profit of Rs 46.7 Cr, with a net margin of 15.28% and earnings per share of Rs 2.87 (standalone statements).
Year-on-year change: revenue +32.45%; net profit +118.11%; EPS +119.08%. Three-year compound annual growth rate: revenue +25.06%; net profit +20.53%.
At the same date the balance sheet shows total assets of Rs 332 Cr, shareholders' equity of Rs 210 Cr, total debt of Rs 71 Cr, cash of Rs 50 Cr, a debt-to-equity ratio of 0.34 and operating cash flow of Rs 79.1 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 331 Cr, net income of Rs 55.8 Cr and a net margin of 16.85%.
Shareholding pattern
In the shareholding pattern for 30 Sept 2026, K M C Speciality Hospitals (India) Limited's ownership is split: promoters 75.00%; foreign institutional investors (FIIs) 0.02%; domestic institutional investors (DIIs) 0.00%; retail and other shareholders 24.98%.
Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding 0.00 percentage points; DII holding 0.00 percentage points.
The same filing lists reported promoter pledge of 0.00% and 91,307 shareholders on record.
Recent filings and corporate actions
44 BSE corporate announcements were filed by K M C Speciality Hospitals (India) Limited in the past twelve months; the most frequent category is "Company Update" (21). The most recent is "Newspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company." (Company Update), filed on 22 Oct 2026.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Hospital. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Dr. Agarwal's Health Care Limited | Rs 488.7 | Rs 15,492 Cr | Rs 2,244 Cr | Rs 185 Cr | 83.70x | 7.62% |
| Rainbow Childrens Medicare Limited | Rs 1,196.8 | Rs 12,155 Cr | Rs 1,857 Cr | Rs 290 Cr | 42.58x | 18.32% |
| Park Medi World Limited | Rs 221.25 | Rs 9,556 Cr | — | — | 32.21x | — |
| Yatharth Hospital & Trauma Care Services Limited | Rs 923.3 | Rs 8,896 Cr | Rs 1,363 Cr | Rs 174 Cr | 49.11x | 10.22% |
| Healthcare Global Enterprises Limited | Rs 591.45 | Rs 8,830 Cr | Rs 2,658 Cr | Rs 33.3 Cr | — | 2.02% |
| Jupiter Life Line Hospitals Limited | Rs 260.1 | Rs 8,527 Cr | Rs 1,660 Cr | Rs 185 Cr | 25.33x | 12.88% |
| Kovai Medical Center & Hospital Limited | Rs 5,896 | Rs 6,452 Cr | Rs 1,673 Cr | Rs 256 Cr | 25.17x | 21.31% |
| Artemis Medicare Services Limited | Rs 297.95 | Rs 4,717 Cr | Rs 1,142 Cr | Rs 114 Cr | 41.44x | 12.82% |
| Indraprastha Medical Corporation Limited | Rs 318.3 | Rs 2,918 Cr | Rs 1,554 Cr | Rs 188 Cr | 15.52x | 28.12% |
| Dr Agarwals Eye Hospital Limited | Rs 5,299.5 | Rs 2,560 Cr | Rs 504 Cr | Rs 76.2 Cr | 33.38x | 27.42% |
| K M C Speciality Hospitals (India) LimitedThis company | Rs 149.36 | Rs 2,436 Cr | Rs 337 Cr | Rs 55.8 Cr | 43.67x | 29.76% |
| Gujarat Kidney And Super Speciality Limited | Rs 171.87 | Rs 1,355 Cr | Rs 103 Cr | Rs 16.7 Cr | 68.47x | 6.27% |
| Shalby Limited | Rs 121.96 | Rs 1,311 Cr | Rs 1,203 Cr | Rs 37.5 Cr | 34.85x | 3.94% |
| GPT Healthcare Limited | Rs 136.89 | Rs 1,123 Cr | Rs 498 Cr | Rs 47.3 Cr | 23.77x | 18.28% |
| Rays of Belief Limited | Rs 261.9 | Rs 410 Cr | — | — | 81.59x | — |
| Median | Rs 279.93 | Rs 3,817 Cr | Rs 1,283 Cr | Rs 144 Cr | 38.14x | 15.58% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to K M C Speciality Hospitals (India)
Same official industry (Hospital)
- Dr. Agarwal's Health Care LimitedAGARWALEYE · Market cap Rs 15,492 Cr
- Rainbow Childrens Medicare LimitedRAINBOW · Market cap Rs 12,155 Cr
- Park Medi World LimitedPARKHOSPS · Market cap Rs 9,556 Cr
- Yatharth Hospital & Trauma Care Services LimitedYATHARTH · Market cap Rs 8,896 Cr
- Healthcare Global Enterprises LimitedHCG · Market cap Rs 8,830 Cr
- Jupiter Life Line Hospitals LimitedJLHL · Market cap Rs 8,527 Cr
- Kovai Medical Center & Hospital LimitedKOVAI · Market cap Rs 6,452 Cr
- Artemis Medicare Services LimitedARTEMISMED · Market cap Rs 4,717 Cr
Other Healthcare companies of a similar market capitalisation
- Syngene International LimitedSYNGENE · Market cap Rs 16,091 Cr
- Vijaya Diagnostic Centre LimitedVIJAYA · Market cap Rs 15,066 Cr
- Jubilant Pharmova LimitedJUBLPHARMA · Market cap Rs 14,947 Cr
- Poly Medicure LimitedPOLYMED · Market cap Rs 14,818 Cr
- Indegene LimitedINDGN · Market cap Rs 14,272 Cr
- Natco Pharma LimitedNATCOPHARM · Market cap Rs 14,097 Cr
- Concord Biotech LimitedCONCORDBIO · Market cap Rs 12,874 Cr
- Blue Jet Healthcare LimitedBLUEJET · Market cap Rs 8,735 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.